webcam-b

Brenntag and K+S announce partnership for pharma salts distribution

Global president of Brenntag Specialties Pharma, Torsten Walz said that adding K+S' pharmaceutical salts would help strengthen their role as a key supplier to the global healthcare industry. (Image source: Brenntag)

Global chemicals and ingredients distribution market leader, Brenntag Specialties Pharma recently announced a new strategic partnership with globally oriented raw materials company, K+S Minerals and Agriculture GmbH for the worldwide distribution of three pharmaceutical salts

K+S which is one of the world's largest producers of pharmaceutical salts, will have three of their salts distributed by Brenntag. These include APISAL Sodium Chloride GMP grade (in pharmacopoeia quality, API), Potassium Chloride 99.9 % KCl Ph. Eur., USP (API) and HD-NaCl (excipient grade). 

The salts are manufactured using special processes to ensure purity and meeting the strict quality requirements of the pharmacopoeias (European Pharmacopoeia, US Pharmacopeia). Examples for final dosage forms are hemodialysis, infusion and injection solutions, electrolyte preparations and tablets. 

Global president of Brenntag Specialties Pharma, Torsten Walz said that adding K+S' pharmaceutical salts would help strengthen their role as a key supplier to the global healthcare industry.

"Our commitment to providing these important ingredients ensures that our customers worldwide have access to the highest quality components needed to produce effective pharmaceuticals, electrolyte therapies and dietary supplements. With this partnership, we combine decades of experience, because not only we at Brenntag are celebrating our 150th anniversary this year, K+S is also celebrating an important milestone: 135 years of company history,” added Waltz.